References and Notes
1
Diederich F.
Cyclophanes
The Royal Society of Chemistry;
Cambridge:
1991.
2
Lehn JM.
Supramolecular Chemistry, Concepts and Perspectives
VCH;
Weinheim:
1995.
3
Purse BW.
Rebek J.
Proc. Natl. Acad. Sci. U.S.A.
2005,
102:
10777
4a
Rebek J.
Science
1987,
235:
1478
4b
Shimizu KD.
Dewey TM.
Rebek J.
J. Am. Chem. Soc.
1994,
116:
5145
4c
Warrener RN.
Margetic D.
Amarasekara AS.
Butler DN.
Mahadevan IB.
Russell RA.
Org. Lett.
1999,
1:
199
5
Adrian JC.
Wilcox CS.
J. Am. Chem. Soc.
1989,
111:
8055
6
Sanderson PEJ.
Kilburn JD.
Still WC.
J. Am. Chem. Soc.
1989,
111:
8314
7
Chen CW.
Whitlock HW.
J. Am. Chem. Soc.
1978,
100:
4921
8
Zimmerman SC.
VanZyl CM.
J. Am. Chem. Soc.
1987,
109:
7894
9
Zimmerman SC.
Wu W.
J. Am. Chem. Soc.
1989,
111:
8054
10
Klärner FG.
Kahlert B.
Acc. Chem. Res.
2003,
36:
919
11
Harmata M.
Acc. Chem. Res.
2004,
37:
862
12a
Klärner FG.
Lobert M.
Naatz U.
Bandmann H.
Boese R.
Chem.-Eur. J.
2003,
9:
5036
12b
Wu A.
Chakraborty A.
Fettinger JC.
Flowers RA.
Isaacs L.
Angew. Chem. Int. Ed.
2002,
41:
4028
13
Dixon RP.
Geib SJ.
Hamilton AD.
J. Am. Chem. Soc.
1992,
114:
365
14a
Paliwal S.
Geib S.
Wilcox CS.
J. Am. Chem. Soc.
1994,
116:
4497
14b
Lagona J.
Fettinger JC.
Isaacs L.
Org. Lett.
2003,
5:
3745
15a
Sijbesma RP.
Nolte RJM.
J. Org. Chem.
1991,
56:
3122
15b
Sijbesma RP.
Wijmenga SS.
Nolte RJM.
J. Am. Chem. Soc.
1992,
114:
9807
15c
Sijbesma RP.
Kentgens APM.
Lutz ETG.
van der Maas JH.
Nolte RJM.
J. Am. Chem. Soc.
1993,
115:
8999
15d
Reek JNH.
Priem AH.
Engelkamp H.
Rowan AE.
Elemans JAAW.
Nolte RJM.
J. Am. Chem. Soc.
1997,
119:
9956
15e
Rowan AE.
Elemans JAAW.
Nolte RJM.
Acc. Chem. Res.
1999,
32:
995
15f
Jansen RJ.
de Gelder R.
Rowan AE.
Scheeren HW.
Nolte RJM.
J. Org. Chem.
2001,
66:
2643
16 Savostianoff DFr. inventors; Patent Appl. 2 291 203.
; Chem. Abstr. 1977, 86, 121377n
17
Mock WL.
Manimaran T.
Freeman WA.
Kuksuk RM.
Maggio JE.
Williams DH.
J. Org. Chem.
1985,
50:
60
18
Liu S.
Wu X.
Zhang S.
Yao J.
Liang F.
Wu C.
New J. Chem.
2004,
28:
562
19
Burnett CA.
Logona J.
Wu A.
Shaw JA.
Coady D.
Fettinger JC.
Day AI.
Isaacs L.
Tetrahedron
2003,
59:
1961
20
Smeets JWH.
Sijbesma RP.
Niele FGM.
Spek AL.
Smeets WJJ.
Nolte RJM.
J. Am. Chem. Soc.
1987,
109:
928
21
Nunen JLM.
Nolte RJM.
J. Chem. Soc., Perkin Trans. 2
1997,
1473
22 Compound 4a: IR (KBr): 3457 (m), 2850 (m), 1762 (s), 1731 (s), 1464 (m), 1419 (m), 1389 (m), 1251 (s), 1173 (m), 1054 (m), 950 (m), 761 (m), 699 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.12 (t, 4 H), 6.94-6.88 (m, 6 H), 5.49 (d, 4 H, J = 13.2 Hz), 4.56 (d, 4 H, J = 13.2 Hz), 4.33 (q, 4 H, J = 6.8 Hz), 1.35 (t, 6 H, J = 6.8 Hz). 13C NMR (100 MHz, CDCl3): δ = 165.13, 157.32, 145.86, 129.24, 121.71, 117.73, 76.13, 63.33, 58.31, 13.84. MS: m/z (%) = 521 (100) [M+], 416 (68), 387 (95), 343 (61), 240 (31), 105 (93).
Compound 4b: IR (KBr): 3456 (m), 2861 (m), 1763 (s), 1731 (s), 1522 (m), 1465 (m), 1418 (m), 1392 (m), 1247 (s), 1176 (m), 1052 (m), 944 (m), 809 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.92 (d, 4 H), 6.83 (d, 4 H), 5.43 (d, 4 H, J = 13.2 Hz), 4.53 (d, 4 H, J = 13.2 Hz), 4.32 (q, 4 H, J = 6.8 Hz), 2.24 (s, 6 H), 1.34 (t, 6 H, J = 6.8 Hz). 13C NMR (100 MHz, CDCl3): δ = 165.18, 157.30, 143.58, 130.92, 129.73, 117.92, 76.09, 63.26, 58.51, 20.44, 13.81. MS: m/z (%) = 549 (100) [M+], 400(91), 356 (41), 118 (88).
Compound 4c: IR (KBr): 3453 (m), 2919 (m), 2847 (m), 1765 (s), 1727 (s), 1465 (m), 1412 (m), 1384 (m), 1248 (s), 1158 (m), 1057 (m), 936 (m), 782 (m), 701 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.04 (2 H), 6.80-6.72 (m, 6 H), 5.46 (d, 4 H, J = 13.2 Hz), 4.51 (d, 4 H, J = 13.2 Hz), 4.33 (q, 4 H, J = 7.2 Hz), 2.20 (s, 6 H), 1.35 (t, 6 H, J = 7.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 165.22, 157.44, 145.98, 139.00, 128.98, 122.84, 118.81, 115.03, 76.09, 63.34, 58.68, 21.44, 13.87. MS: m/z (%) = 549 (100) [M+], 400(97), 356 (49), 118 (60).
Compound 4d: IR (KBr): 3451 (s), 2987 (m), 2939 (m), 1768 (s), 1729 (s), 1515 (s), 1463 (m), 1416 (m), 1284 (m), 1242 (s), 1179 (m), 1032 (m), 824 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 6.93 (d, 4 H, J = 8.8 Hz), 6.71 (d, 4 H, J = 8.8 Hz), 5.34 (d, 4 H, J = 12.8 Hz), 4.53 (d, 4 H, J = 12.8 Hz), 4.33 (q, 4 H, J = 7.2 Hz), 3.73 (s, 6 H), 1.34 (t, 6 H, J = 7.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 165.21, 157.48, 154.91, 139.73, 120.12, 114.40, 76.05, 63.27, 59.32, 55.20, 13.83. MS: m/z (%) = 581 (100)[M+], 416 (41), 372 (26), 191 (27), 176 (30), 134 (99), 120 (71).
Compound 4e: IR (KBr): 3457 (m), 2962 (m), 1753 (s), 1737 (s), 1261 (s), 1093 (s), 1050 (s), 802 (s) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.05 (d, 4 H, J = 8.8 Hz), 6.90 (d, 4 H, J = 8.8 Hz), 5.41 (d, 4 H, J = 12.8 Hz), 4.49 (d, 4 H, J = 12.8 Hz), 4.33 (q, 4 H, J = 7.2 Hz), 2.78-2.82 (m, 2 H), 1.34 (d, 6 H, J = 7.2 Hz), 1.18 (d, 12 H, J = 2.4 Hz). 13C NMR (100 MHz, CDCl3): δ = 165.32, 157.63, 144.01, 142.63, 127.13, 118.49, 76.14, 63.33, 59.20, 33.21, 23.95, 13.92. MS: m/z (%) = 605 (100) [M+], 428 (74), 385 (45), 287 (28), 202 (28), 146 (40), 132 (83).
Compound 4f: IR (KBr): 3411 (s), 1765 (s), 1722 (s), 1498 (m), 1468 (m), 1415 (s), 1238 (s), 1048 (m), 903 (m), 833 (m), 717 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.02 (d, 4 H, J = 8.8 Hz), 6.82 (d, 4 H, J = 8.8 Hz), 5.48 (d, 4 H, J = 14.0 Hz), 4.62 (d, 4 H, J = 14.0 Hz), 4.33 (q, 4 H, J = 7.2 Hz), 1.35 (t, 6 H, J = 7.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 164.93, 157.10, 144.22, 129.21, 126.47, 118.46, 76.20, 63.53, 57.61, 13.87. MS: m/z (%) = 590 (100) [M+], 538 (21), 420 (70), 376 (27), 202 (25), 191 (9), 189 (21), 145 (65).
Compound 4g: IR (KBr): 3448 (m), 2981 (w), 2936 (w), 1746 (s), 1726 (s), 1496 (m), 1467 (m), 1417 (m), 1280 (m), 1239 (s), 1094 (m), 1047 (m), 975 (m), 908 (m), 818 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.18 (d, 4 H, J = 8.8 Hz), 6.77 (d, 4 H, J = 8.8 Hz), 5.48 (d, 4 H, J = 14.0 Hz), 4.62 (d, 4 H, J = 14.0 Hz), 4.34 (q, 4 H, J = 7.2 Hz), 1.35 (t, 6 H, J = 7.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 164.87, 157.04, 144.77, 132.15, 118.88, 113.93, 76.16, 63.51, 57.53, 13.86. MS: m/z (%) = 679 (73) [M+], 467 (58), 466 (10), 464 (66), 423 (30), 420 (26), 409 (4), 243 (10), 241 (24), 240 (63), 182 (100).
Compound 4h: IR (KBr): 3426 (m), 1749 (s), 1727 (s), 1493 (m), 1466 (m), 1417 (m), 1279 (m), 1245 (s), 1174 (m), 1093 (m), 909 (m), 812 (m), 694 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.37 (d, 4 H, J = 7.6 Hz), 6.66 (d, 4 H, J = 7.6 Hz), 5.47 (d, 4 H, J = 14.0 Hz), 4.61 (d, 4 H, J = 14.0 Hz), 4.33 (q, 4 H, J = 7.2 Hz), 1.34 (t, 6 H, J = 7.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 164.95, 157.11, 145.62, 138.20, 119.46, 84.29, 76.24, 63.56, 57.62, 13.94. MS: m/z (%) = 723 (93) [M+], 647 (13), 513 (70), 387 (18), 231 (100), 208 (48).
23 Crystal data for compound 4d: C28H32N6O8, M = 580.60, triclinic, a = 7.5266 (18), b = 13.438 (3), c = 14.167 (3) Å, a = 87.547 (4)°, β = 83.627 (4)°, γ = 81.942 (4)°, U = 1409.4 (6) Å3, T = 292 (2) K, space group P-1, Z = 2, µ (Mo-Kα) = 0.102 mm-1, 7110 reflections measured, 4870 unique (R
int = 0.0216) which were used in all calculations. The final wR
2 (F
2) was 0.1816 (all data). CCDC-281947 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44(1223)336033; email: deposit@ccdc.cam.ac.uk]